GT Biopharma, Inc. (GTBP) vs ENDRA Life Sciences Inc. (NDRA)
A side-by-side comparison of GT Biopharma, Inc. and ENDRA Life Sciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GTBP
GT Biopharma, Inc.
$6.37HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
NDRA
ENDRA Life Sciences Inc.
$6.04HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — GTBP vs NDRA
growth of $100 · dividends reinvested · last 9yGTBP -100.0% (-64.9%/yr)NDRA -100.0% (-67.0%/yr)GTBP compounded faster over this window
GTBP NDRA
GTBP vs NDRA: by the numbers
- •GTBP is the larger company ($8M vs $8M market cap).
Metrics side by side
Valuation
| Metric | GTBP | NDRA |
|---|---|---|
| P/B ratio | 2.25 | 1.22 |
Profitability
| Metric | GTBP | NDRA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -618.74% | -93.77% |
| ROIC | -457.75% | -92.93% |
Growth (annualized)
| Metric | GTBP | NDRA |
|---|---|---|
| Total return CAGR (5Y) | -73.13% | -83.91% |
Frequently asked
- How have GTBP and NDRA total returns compared?
- Over the past 5 years, GTBP delivered -73.13% and NDRA delivered -83.91% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.